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Abstract 
Background: Respiratory viruses circulate constantly in the ambient air. The risk of opportunistic infection from these 
viruses can be increased in mechanically ventilated patients. The present study evaluates the feasibility of detecting 
airborne respiratory viruses in mechanically ventilated patients using a novel sample collection method involving 
ventilator filters.
Methods: We collected inspiratory and expiratory filters from the ventilator circuits of mechanically ventilated 
patients in an intensive care unit over a 14-month period. To evaluate whether we could detect respiratory viruses 
collected in these filters, we performed a reverse transcription polymerase chain reaction on the extracted filter mem-
brane with primers specific for rhinovirus, respiratory syncytial virus, influenza virus A and B, parainfluenza virus (type 
1, 2 and 3) and human metapneumovirus. For each patient, we also performed a full virology screen (virus particles, 
antibody titres and virus-induced biomarkers) on respiratory samples (nasopharyngeal swab, tracheal aspirate or 
bronchoalveolar fluid) and blood samples.
Results: Respiratory viruses were detected in the ventilator filters of nearly half the patients in the study cohort 
(n = 33/70). The most common virus detected was influenza A virus (n = 29). There were more viruses detected in the 
inspiratory filters (n = 18) than in the expiratory filters (n = 15). A third of the patients with a positive virus detection in 
the ventilator filters had a hospital laboratory confirmed viral infection. In the remaining cases, the detected viruses 
were different from viruses already identified in the same patient, suggesting that these additional viruses come from 
the ambient air or from cross-contamination (staff or visitors). In patients in whom new viruses were detected in the 
ventilator filters, there was no evidence of clinical signs of an active viral infection. Additionally, the levels of virus-
induced biomarker in these patients were not statistically different from those of non-infected patients (p = 0.33).
Conclusions: Respiratory viruses were present within the ventilator circuits of patients receiving mechanical ventila-
tion. Although no adverse clinical effect was evident in these patients, further studies are warranted, given the small 
sample size of the study and the recognition that ventilated patients are potentially susceptible to opportunistic 
infection from airborne respiratory viruses.
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Background
Influenza and other respiratory viruses spread via three 
main transmission routes, namely direct contact, respira-
tory droplets and airborne transmission. The first two 
routes (direct contact and respiratory droplets) can be 
reduced by infection control measures (e.g. hand washing 
and wearing face masks). The third route, airborne trans-
mission, is difficult to prevent since respiratory viruses 
are ubiquitous in the environment and virus particles 
constantly circulate in the air [1]. The concentration of 
airborne viruses is usually low and insufficient to cause 
disease in humans; however, in those with a compro-
mised immune system (e.g. critically ill patients), the risk 
of infection increases dramatically [2].
The risk of infection from circulating respiratory 
viruses is higher in mechanically ventilated patients com-
pared to non-ventilated patients. These patients have an 
exposed lower airway (the endotracheal tube bypasses the 
upper airway defence which normally acts as a physical 
barrier to airborne viruses). In addition, they have mul-
tiple risk factors that may further compromise their host 
defence system, including local trauma (due to intuba-
tion and airway manipulation), a weakened local defence 
(from a loss of mucociliary clearance and cough reflex) 
and a diminished immune response (e.g. reduced alveolar 
macrophages in the lungs). Despite this increased infec-
tion risk, the air in the ICU is not routinely sampled for 
the presence of respiratory viruses because no method is 
currently available for measuring airborne viruses.
The aim of the present study was to evaluate the 
effectiveness of a novel sampling method that collected 
inspired/expired air within the ventilator circuit to allow 
for the measuring of airborne viruses. Detecting airborne 
viruses in these patients is technically challenging as the 
concentration of viruses in the inspired/expired air is 
usually very low; a substantially large volume of air per 
sample is required for detection. To address this chal-
lenge, we applied a novel approach in which we measured 
viruses trapped in the ventilator filters of mechanically 
ventilated patients. The ventilator filters have a large 
volume of inspired/expired air circulating through them 
each day, thus making them an ideal medium for sam-
pling airborne viruses. Here, we report the findings of a 
feasibility study using ventilator filters to detect airborne 




We recruited mechanically ventilated patients in 
an intensive care unit over a 14-month period. Eli-
gible patients included those (1) over 18  years old; 
(2) suspected of having pneumonia with a viral 
aetiology (“flu-like” illness in the preceding 7 days); and 
(3) mechanically ventilated for at least 24 h. Pneumonia 
was defined as a new lung infiltrate on chest radiography 
at hospital admission with symptoms and signs of lower 
respiratory tract infection. “Flu-like” illness was defined 
as having at least one symptom from two or more symp-
toms categories. The symptom categories were as follows: 
(1) fever, (2) constitutional symptoms (e.g. chill, head-
ache, muscle ache) and (3) respiratory symptoms (e.g. 
cough, sore throat, nasal congestion). Informed consent 
was obtained from relatives or the legal guardian of the 
patient. The study was approved by the human ethics 
committee of our institution.
Filter collection
To evaluate whether we could detect respiratory viruses in 
the inspired/expired air, we sampled both the inspiratory 
and expiratory filters from the ventilator circuits (Fig. 1). 
After the first 24  h of mechanical ventilation, ventilator 
filters were collected, placed in pre-prepared sample bags 
and stored in − 80 °C for later processing (see below). 
Processing
Prior to the processing of the filters, care was taken 
to ensure that the filters were not exposed to ambi-
ent air during transportation. During processing, filters 
were first dismantled to allow the filter membrane to 
be extracted. 1  ml of Bioline Lysis Buffer RLY (Bioline, 
Alexandria, Australia) was then added to the filter mem-
brane in a tube, followed by centrifugation for 2 min at 
2000 rpm. The full 1 mL of eluate was collected after the 
final spin and stored at − 20  °C until RNA extraction. 
Viral RNA in the eluate was extracted using the Isolate 
II RNA Mini Kit (Bioline, Alexandria, Australia) as per 











Fig. 1 Ventilator circuit with the position of filters shown. A simpli-
fied schematic drawing showing the position of the inspiratory and 
expiratory filters (highlighted in red). Arrows inside each arm of the 
ventilator circuit indicate the direction of air flow
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Virus detection in filters
The reverse transcription polymerase chain reaction (RT-
PCR) (Bioline, Alexandria, Australia) was performed 
on the extracted filter membrane to detect rhinovi-
rus, respiratory syncytial virus, influenza virus A and B, 
parainfluenza virus (type 1, 2 and 3) and human metap-
neumovirus. As an internal control, positive viral cDNA 
was included in each PCR assay. All primer sequences are 
provided in the (Additional file 1: Table S1).
Extracted RNA was converted to cDNA using the 
Bioline SensiFAST cDNA Synthesis Kit (Bioline, Alex-
andria, Australia) as per manufacturer’s instructions, 
with 8  μl of extracted RNA, 7  μl of DPEC water, 4  μl 
reaction buffer, 1  μl of reverse transcriptase added 
to each reaction to make a total volume of 20 μl. The 
PCR assay was performed as follows: all samples were 
run in triplicate, with 2 μl of cDNA template added to 
Bioline SensiFAST Probe Hi-ROX Master Mix. Spe-
cific primers and probes (Table 1) for each virus were 
added to the PCR assay along with DEPC water. The 
dual-labelled probes utilised the FAM fluorophore 
and BHQ-1 quencher. These samples were run on the 
StepOnePlus Real-Time PCR System (Applied Biosys-
tems, California, USA) for 40 cycles. The threshold 
was automatically detected based on amplification. 
Positive viral samples and negative controls were run 
individually for each assay.
Additional laboratory tests
In addition to ventilator filters, clinical respiratory 
samples were collected from each patient, including a 
nasopharyngeal swab, tracheal aspirate and/or bron-
choalveolar fluid. Multiplex viral PCR (BioFire FilmAr-
ray, Salt Lake City, USA) was performed to detect the 
presence of rhinovirus, respiratory syncytial virus, influ-
enza virus A and B, parainfluenza virus (type 1, 2 and 3) 
and human metapneumovirus in these samples. Assay 
characteristics and methodology of this multiplex viral 
PCR have been previously published [3–5]. This clinical 
testing was performed by the hospital laboratory scien-
tists, separate from the researchers who performed the 
PCR assay on the ventilator filters. The researchers who 
performed the PCR assay on the ventilator filters were 
blind to the results of the multiplex viral PCR and vice 
versa. Tests for bacterial pathogens were also carried for 
each patient, including both typical and atypical respira-
tory pathogens.
Serology and host response biomarker
To assess the host response to respiratory viruses, a 
blood sample was taken from each patient to meas-
ure (1) serological changes and (2) biomarker IFI27 
changes. For the serological test, a positive seroconver-
sion to influenza virus is defined as a low baseline anti-
body titre (< 1:10) followed by an increase (> 4 fold) in 
antibody titre between the two blood samples. For the 
IFI27 biomarker, an increased IFI27 gene expression 
in peripheral blood indicates an immune response to a 
specific respiratory virus with the following threshold 
cut-off values: influenza (> 74 fold change), parainflu-
enza virus (> 74 fold change), respiratory syncytial virus 
(> 40 fold change) and human metapneumovirus (> 40 
fold change) [6].
Statistical analysis
For continuous variables, comparisons between two 
groups were made using an unpaired two-tailed Student’s 
t test or the nonparametric Mann–Whitney U test, where 
appropriate. For categorical variables, comparisons 
between two groups were calculated using Fisher’s exact 
test. Statistical significance was defined as p < 0.05.
Results
Technical feasibility study
We first assessed the feasibility of detecting respiratory 
viruses in clean, unused ventilator filters. To this end, we 
inoculated two different respiratory viruses (influenza A 
and rhinovirus) using viral stock onto clean ventilator fil-
ters. These filters were then stored for 1, 2 and 4 weeks 
under different temperatures (room temperature or 
− 20  °C). After the storage period, we extracted the fil-
ter membrane from each filter casing and amplified viral 
nucleic acids using RT-PCR (as described in the Methods 
section). We detected viral nucleic acids after 1 week at 
room temperature and up to 4 weeks at − 20 °C (Table 1). 
Both influenza virus and rhinovirus were recovered in 
the inoculated filters (Table 1). This finding demonstrates 
the feasibility of using ventilator filters as a collection 
device, providing the basis for our sampling approach 
subsequently used in this study.
Table 1 Virus inoculation and subsequent recovery by PCR
10 uL of viral stock was inoculated onto each ventilator filter. These filters were 
then stored at either room temperature (20 °C) or low temperature (− 20 °C) for 
1, 2 or 4 weeks. Triplicates were stored for each condition









Virus added 20 °C Detected No No




Virus added 20 °C Detected No No
Virus added − 20 °C Detected Detected Detected
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Airborne viruses in ventilated patients
Having demonstrated the technical feasibility of our 
sampling method, we next investigated whether we 
could detect airborne viruses in mechanically ventilated 
patients. A total of 35 mechanically ventilated patients 
were recruited for the study. Full, detailed demographic 
and clinical features of the patients are provided in 
Table 2. In brief, 35 patients were admitted to the inten-
sive care unit for the management of respiratory failure. 
Thirty of these 35 patients had pneumonia. Five patients 
had no evidence of infection—these patients acted as 
controls in the study. Infectious agents identified in the 
patients with pneumonia included viruses (n = 20), bac-
teria (n = 18), fungi (n = 1) and virus–bacteria co-infec-
tion (n = 8). A full list of identified infectious agents is 
provided in the (Additional file  2: Table S2). No infec-
tious agents were identified in the control patients after a 
full microbiological and virology screen on each patient’s 
blood, urine and airway samples.
A total of 70 ventilator filters were collected from the 
recruited patients, with one expiratory filter and one 
inspiratory filter collected from each patient. Airborne 
respiratory viruses were detected in nearly half of the fil-
ters (n = 33) using RT-PCR (Table  3). There were more 
viruses detected in the inspiratory filters (n = 18) than in 
the expiratory filters (n = 15). The most common virus 
detected was the influenza A virus (n = 29).
Inspired air versus expired air
We hypothesised that the expired air reflects the virus 
ecology inside the patients’ lungs. This means the dis-
tribution of viruses detected in the expiratory filters 
would resemble the viruses circulating in the local 
patient population, which would display seasonal fluc-
tuations related to the onset/end of each flu season. To 
assess the impact of seasonal changes on virus detec-
tion in inspired/expired air, we divided the recruit-
ment period into stages including (1) peak flu seasons 
and (2) off-peak flu season (Fig. 2). In this analysis, we 
found that the airborne viruses in the expiratory filters 
did show a seasonal pattern and matched the seasonal 
increase/decrease reported in our local institution 
(data not shown). In contrast, no seasonal fluctuation 
was observed in the influenza viruses detected in the 
inspiratory filters (Fig. 2), in keeping with the fact that 
inspired air came from the main hospital air supply 
(which is insulated from the viruses circulating in the 
local population) (Table 3).  
Sources of airborne viruses
Having demonstrated the presence of airborne viruses 
in mechanically ventilated patients, we next sought to 
identify the possible sources of these airborne viruses. 
A third of the cases (n = 9) were found in patients with 
an established diagnosis of respiratory virus infection, 
indicating that these patients were actively shedding 
viruses during the study period and some of these virus 
particles were detected by our method. In the remaining 
cases, the detected viruses were different from viruses 
identified in the respiratory secretions of the same 
patient, suggesting that these new viruses might come 
from either the ambient air (from routine change of the 
patient’s ventilator circuit) or from cross-contamination 
(staff or visitors).
Host response to airborne viruses
We next assessed the acute host response to the presence 
of airborne viruses in each patient. To this end, we ana-
lysed patients’ peripheral blood samples to measure the 
gene expression levels of the biomarker IFI27, an estab-
lished marker of virus-induced immune response [3]. 
We compared the IFI27 levels between patients with an 
established diagnosis of viral infection, patients in whom 
a new virus was detected (in their ventilator filters) and 
patients in whom no respiratory virus was found any-
where (in blood, respiratory secretions or ventilator 
filters). We found that IFI27 levels were significantly ele-
vated in those with confirmed respiratory viral infection 
(mean fold change = 483), confirming the presence of 
an immune response to the viral infection. In patients in 
whom a new virus was detected in their ventilator filters, 
the IFI27 levels were low (mean fold change = 13) and 
not statistically different to patients who had no evidence 
of viral infection (Fig. 3); this result suggested an absence 
of virus-induced immune response in these patients 
(Table 4).
Table 2 Patient demographic and clinical characteristics
a Data are presented as mean and range (minimum–maximum)
Infected patients Control patients
Number of patients 30 5
Age (years)a 58.6 (23–86) 52.6 (21–71)
Gender (male/female) 10/20 3/2
Infection types
 Bacterial 8 0
 Viral 11 0
 Bacteria–bacteria 2 0
 Virus–bacteria 8 0
 Virus–fungus 1 0
Severity and outcomes
 APACHE III  scoresa 67 (36–128) 57 (35–83)
 Length of ventilation (days)a 8.7 (2–28) 3.8 (1–8)
 Length of ICU stay (days)a 11.5 (2–37) 6 (2–11)
 Length of hospital stay (days)a 16 (2–45) 8.6 (2–16)
 Alive/dead 22/8 5/0
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Discussion
This is the first report to assess the feasibility of using a 
novel sampling method to detect airborne respiratory 
viruses in a critically ill patient population. The results 
show that airborne viruses were present in 44% of the 
ventilator filters collected from mechanically ventilated 
patients. The vast majority of the detected airborne 
viruses (88%) were influenza viruses. In some cases, the 
airborne viruses detected reflected the carrier status of 
the patients, with the same virus found in both the ven-
tilator filter and patients’ respiratory secretions. In other 
cases, where a new virus was detected, the clinical signifi-
cance of these viruses remains unclear, since the affected 
patients showed no evidence of a virus-induced immune 
response.
A large number of studies have demonstrated that 
respiratory viruses (e.g. influenza viruses) are always 
present in the ambient air [2]. The importance of detect-
ing airborne viruses present in the hospital environment 
is increasingly being recognised. Several recent stud-
ies have provided a direct demonstration that influenza 
viruses were present in aerosolised droplets from the 
tidal breathing of infected persons and in the air of the 
emergency department [7, 8]. During peak flu season, 
the concentration of airborne viruses in the environ-
ment rises to 5800–37,000 virus particles per  m3. At this 
concentration, breathing air for 1 h is sufficient to cause 
clinical infection in a previously unexposed person [9]. 
Thus, monitoring airborne virus concentrations may be 
important in a high-risk clinical environment such as the 
intensive care unit, where many patients have immune-
compromised status and an increased susceptibility to 
opportunistic infection. Furthermore, there is significant 
risk of droplet transmission if visitors or healthcare staff 
Fig. 2 Seasonal changes in the frequency of detected viruses. The recruitment period covered two flu seasons in the Southern hemisphere one 
inter-seasonal period. “2016” refers to the first flu season (early July–late October 2016). “2017” refers to the second flu season (late July–mid-October 
2017). “Inter-flu season” refers to the period in between the two seasons (November 2016 to early July 2017). p values were calculated using Fisher 
exact test. No difference was detected in the distribution of detected viruses in the inspiratory filters
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are infected with respiratory viruses and are in close con-
tact with these critically ill patients. The method outlined 
in this study may provide a tool to monitor both airborne 
and droplet sized viral particles that mechanically venti-
lated patients are exposed to.
Monitoring airborne viruses requires a different 
approach than the conventional testing method of res-
piratory viruses. This difference is due to the fact that the 
concentration of viruses in the ambient air is much lower 
than that of the respiratory secretions (e.g. nasopharyn-
geal swab or bronchoalveolar lavage). Unfortunately, 
there is a lack of data on detection method specifically 
developed for airborne viruses. This study represents 
the first step towards developing a reliable, easy-to-per-
form method for airborne virus detection. Future studies 
should investigate whether such methods could increase 
the diagnostic yield of detecting viral aetiology in patients 
with community-acquired pneumonia or whether such 
methods could prevent hospital-acquired viral infection 
in mechanically ventilated patients.
Table 3 Airborne viruses in patients’ ventilator filters
a Infected patients refer to pneumonia patients in whom a bacterium was 
identified by culture or a respiratory virus was identified either by PCR assay on 
respiratory secretions (e.g. nasopharyngeal swap, bronchoalveolar lavage fluid) 

























Fig. 3 Host response biomarker and clinical outcomes. “Confirmed viral infection” group refers to all patients in whom a respiratory virus was identi-
fied in their respiratory secretions (e.g. nasopharyngeal swap, bronchoalveolar lavage fluid) or increased anti-viral titres in their serum as measured 
by serology. “Airborne viruses detected” group refers to patients in whom a new respiratory virus was detected in the inspiratory filter or the expiratory 
filter. “No viruses detected” group refers to patients in whom no respiratory virus was detected in the respiratory secretions, serum or the ventilator 
filters. The IFI27 mRNA-expression was measured by quantitative real-time PCR, and its level is expressed as fold change (relative to GAPDH). The p 
values were calculated using Kruskal–Wallis test (for comparison of multiple groups). The error bars are mean plus standard deviation
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There are additional challenges with investigating air-
borne respiratory viruses in critically ill patients due to 
experimental difficulties in sampling aerosolised virus 
particles, including the potential inactivation of viruses 
by current sampling methodology [10]. To overcome this 
sampling difficulty, we used ventilator filters as a collec-
tion device, since these filters collect a large volume of 
air which potentially increases the yield of detected virus 
particles. This approach was first tested in the pilot phase 
of this study, in which we inoculated live viruses into 
clean, unused filters. Days later, we were able to recover 
the same viruses in the filters. This finding provides 
strong support for using this approach in our study. The 
result is also in keeping with findings from a previous 
study by Heuer et al., who demonstrated that aerosolised 
influenza virus particles could be trapped inside ventila-
tor filters [11]. In Heuer’s study, three different brands 
of commercially available filters were tested; all showed 
that the filters could successfully collect airborne viruses. 
Whilst the Heuer study was designed as an in vitro study, 
our study provides real-world data in a clinical setting. 
Collectively, both the in  vitro and the clinical data con-
firm the technical feasibility of using ventilator filters as a 
collection device.
We used a RT-PCR assay to detect viruses in the pre-
sent study, which is the method of choice for airborne 
viruses suggested by the established literature [1]. We 
purposefully adopted a more sensitive detection thresh-
old (cycle threshold (Ct) value of 37–38) in order to 
quantify the lowest background virus level inside the 
ventilator circuits. This information allowed us assess the 
baseline risk level of airborne viruses in our clinical envi-
ronment. It is important to note that the low detection 
threshold used in this study detects viruses at concentra-
tions less than 500 virus particles per  m3 [12]. Such a low 
virus concentration is generally insufficient to breach the 
normal defence barrier of the host’s airways and, hence, is 
unlikely to cause clinical infection in the affected individ-
ual. This helps explain the observation that there was no 
evidence of virus-induced immune response in patients 
in whom a virus was detected in the filters and the clini-
cal course/outcomes of these patients did not differ from 
the control patients.
The current study has some limitations, first of which 
was a small sample size and selected cohort of patients, 
meaning the generalisability of the findings to other 
patient populations is limited. As part of this, it was 
impossible to determine the original size of the viral par-
ticles that were collected on ventilator filters making it 
difficult to delineate whether this was detection of air-
borne transmission, droplet transmission or a combina-
tion of the two. Secondly, we did not quantify the number 
of virus particles in the collected samples (ventilator filter 
or respiratory samples). As a result, no information was 
available regarding the precise viral load in each sample. 
Thirdly, we did not perform sequencing of the identified 
viruses, making it difficult to know with certainty the 
exact source of each virus. Fourthly, we did not assess 
whether the detected virus particles could replicate in 
human cells and therefore had no information regard-
ing the viruses’ viability or infectivity, both of which are 
clinically important. A further limitation of this study is 
Table 4 Virus detected in each patient
RSV respiratory syncytial virus, HMPV human metapneumovirus, PIV 
parainfluenza virus
a In this column, “Infected” refers to any of the following status; (1) bacterial 
infection, (2) viral infection or (3) viral–bacterial co-infection
Subjects Statusa Airway Serology Inspiratory Expiratory
1 Infected Influenza Influenza
2 Infected RSV Influenza Influenza
3 Infected Influenza Influenza
4 Infected Rhinovirus Influenza Influenza
5 Control
6 Infected Influenza PIV Influenza
7 Infected Influenza PIV
8 Infected Rhinovirus
9 Control Influenza Influenza
10 Infected
11 Infected Rhinovirus Influenza
12 Control Influenza
13 Infected PIV
14 Control Influenza Influenza
15 Infected Rhinovirus Influenza Influenza









25 Infected HMPV HMPV
26 Infected Influenza
27 Infected Influenza Influenza
28 Infected Influenza Influenza Influenza
29 Infected Influenza Influenza
30 Infected Influenza Influenza Influenza
31 Control Influenza
32 Infected Influenza Influenza
33 Infected Influenza
34 Infected Influenza Influenza Rhinovirus
35 Infected Influenza Influenza
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that 24 h was used as a sampling time; it is possible that 
a longer sampling time (e.g. 48 h, 72 h) may increase the 
yield of virus detection.
Conclusion
This preliminary study shows that it is technically feasi-
ble to detect airborne viruses in the ventilator filters col-
lected from patients receiving mechanical ventilation. 
Our findings provide important baseline data regarding 
the presence of airborne viruses in critically ill patients 
and may help inform the design of future studies in a 
similar setting.
Abbreviations
Ct: cycle threshold; RT-PCR: reverse transcriptase polymerase chain reaction.
Authors’ contributions
ABM, BT and BGGO were involved in the design of this study; BT, LSB were 
involved in participant recruitment and sample collection; ABM, LSB, MS, MN 
were involved in sample processing and experimentation; ABM, BT, MS, LSB, 
MN, BGGO, AM were all involved in manuscript preparation and editing. All 
authors read and approved the final manuscript.
Author details
1 School of Life Sciences, University of Technology Sydney, Sydney, NSW 2007, 
Australia. 2 Department of Intensive Care Medicine, Nepean Hospital, Sydney, 
Australia. 3 Centre for Immunology and Allergy Research, Westmead Institute 
for Medical Research, Sydney, Australia. 4 Respiratory Virus Infection Research, 
Marie Bashir Institute for Infectious Diseases and Biosecurity, Sydney, Australia. 
5 Nepean Clinical School, Faculty of Medicine, University of Sydney, Sydney, 
Australia. 
Acknowledgements
Nepean hospital intensive care unit staff who provided the collection of venti-
lator filers and patient samples.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets used and/or analysed during the current study are available from 




Additional file 1: Table S1. Virus-specific primer and probe sequences 
for real-time PCR.
Additional file 2: Table S2. Pathogens identified in patient  samplesψ 
(excluding ventilator filers samples).
Ethics approval and consent to participate
Ethics approval had been granted by the Nepean Blue Mountains Local Health 
District Human Research Ethics Committee—Nepean (HREC/15/NEPEAN/130), 
and all subjects gave written informed consent to participate.
Funding
This research is supported by an Australian Government Research Training 
Program Scholarship and the Sydney Medical School Foundation.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Received: 15 January 2018   Accepted: 12 April 2018
References
 1. Nikitin N, Petrova E, Trifonova E, Karpova O. Influenza virus aerosols in the 
air and their infectiousness. Adv Virol. 2014;2014:859090–6.
 2. Hall CB. The spread of influenza and other respiratory viruses: complexi-
ties and conjectures. Clin Infect Dis. 2007;45:353–9.
 3. Chen H, Weng H, Lin M, He P, Li Y, Xie Q, Ke C, Jiao X. The clinical signifi-
cance of FilmArray respiratory panel in diagnosing community-acquired 
pneumonia. Biomed Res Int. 2017;2017:7320859.
 4. Rogers BB, Shankar P, Jerris RC, Kotzbauer D, Anderson EJ, Watson 
JR, O’Brien LA, Uwindatwa F, McNamara K, Bost JE. Impact of a rapid 
respiratory panel test on patient outcomes. Arch Pathol Lab Med. 
2015;139:636–41.
 5. Andrews D, Chetty Y, Cooper BS, Virk M, Glass SK, Letters A, Kelly PA, 
Sudhanva M, Jeyaratnam D. Multiplex PCR point of care testing versus 
routine, laboratory-based testing in the treatment of adults with respira-
tory tract infections: a quasi-randomised study assessing impact on 
length of stay and antimicrobial use. BMC Infect Dis. 2017;17:671.
 6. Tang BM, Shojaei M, Parnell GP, Huang S, Nalos M, Teoh S, et al. A 
novel immune biomarker IFI27 discriminates between influenza and 
bacteria in patients with suspected respiratory infection. Eur Respir J. 
2017;49:1602098.
 7. Tellier R. Aerosol transmission of influenza A virus: a review of new stud-
ies. J R Soc Interface. 2009;6:S783–90.
 8. Stelzer-Braid S, Oliver BG, Blazey AJ, Argent E, Newsome TP, Rawlinson 
WD, et al. Exhalation of respiratory viruses by breathing, coughing, and 
talking. J Med Virol. 2009;81:1674–9.
 9. Yang W, Elankumaran S, Marr LC. Concentrations and size distributions of 
airborne influenza A viruses measured indoors at a health centre, a day-
care centre and on aeroplanes. J R Soc Interface. 2011;8:1176–84.
 10. Verreault D, Moineau S, Duchaine C. Methods for Sampling of Airborne 
Viruses. Microbiol Mol Biol Rev. 2008;72:413–44.
 11. Heuer JF, Crozier TA, Howard G, Quintel M. Can breathing circuit filters 
help prevent the spread of influenza A (H1N1) virus from intubated 
patients? GMS Hyg Infect Control. 2013;8:Doc09.
 12. Stone B, Burrows J, Schepetiuk S, Higgins G, Hampson A, Shaw R, et al. 
Rapid detection and simultaneous subtype differentiation of influenza A 
viruses by real time PCR. J Virol Methods. 2004;117:103–12.
